Upgrade to Pro

Pharmaceutical Excipients Market Share, Trends, Opportunities, Growth Analysis and Forecast to 2030

Pharmaceutical Excipients Market

Pharmaceuticals are important components of a formulation that offers effective drug absorption. Excipients must comply with the regulatory requirements and must suit the intended dosage form. The compatibility is crucial in dosage forms that incorporate coating, controlled and sustained release, oil base (emulsifiers), and taste masking.

The Pharmaceutical Excipients Market Share will witness a CAGR of 7.89 %, along with a value of USD 9.35 billion by 2030 in the forecast period.

Excipients used in the manufacturing of drug serve as binders, disintegrants, glidants, or diluents. Therefore, multifunctional excipients can reduce the manufacturing cost and drug development of the product.

Drivers and Restraints

Owing to the patent expiries, the market has witnessed a robust growth rate in the recent times. Moreover, with the large patient population base and growing demand for pharmaceutical products will propel the growth of the market globally. Factors like increasing chronic diseases, growing generics market owing to patent cliffs, advancement in the development of functional excipient, rapid growth of biopharmaceuticals, growing biosimilar industry, and emergence of co-processed and multifunctional excipients are the major factors fuelling the market growth.

Meanwhile, strict mandates like inspection of manufacturing sites by regulatory authorities such as MHRA, FDA, and TGA has affected the supply of global pharmaceutical excipients. Lack of separate guidelines for approval and manufacturing of excipients is impending R&D initiatives related to excipients. If a new drug approval fails, the excipient also fails even if it is not related to the excipient. The clinical data from that particular excipient cannot be used. Moreover, the timeframe and cost required to develop excipients are uneconomical for the manufacturers, thus limiting the scope for getting an excipient approved.

Pharmaceutical Excipients Market Outlook and Analysis by Function (Binder, Lubricant, Filler, Coating), Application (Oral, Parenteral, Topical), Product (Organic Chemicals, Inorganic Chemicals) - Forecast 2030

Major Key Players:

Some of the Key Market Players are Evonik Industries Ag, Basf Se, Ferro Corporation, P&G Chemicals, Akzo Nobel NV, FMC Corporation, The Dow Chemical Company, Ashland, Inc., Croda International PLC

Segment Analysis

The global market for pharmaceutical binders can be segmented on the basis of product, functions, applications, and region.

The market has been segmented into organic and inorganic chemicals based on product.

The market has been segmented into glidants, lubricants, fillers, coatings, preservatives, disintegrants, binders, and others on the based on functions. Fillers have been accounted to hold the largest market share. They provide ease of administration and improve the taste of the formulation. They also offer ease in preparation, stability, shipping, packaging, and dispensing of drugs.

The market for pharmaceuticals excipients has also been segmented into parenteral, oral, topical, and advanced delivery system based on applications. Oral and topical dosage forms are anticipated to drive the pharmaceuticals excipients market growth. Consumption of excipients is witnessed to be high in oral dosage forms like capsules, tablets, and liquids, compared to parenteral. Local players mark their entry in pharmaceuticals with oral dosage forms as they are easier to manufacture. Also, with increasing topical solutions such as gel, cream, skin patch, and eye drops in pain management and dermatology, demand for excipients is also expected to grow at a steady pace.

Regional Analysis

North America has been anticipated to hold the largest market share and is expected to grow over the forecast period. The major factor for growth in this region is due to the presence of European Medicines Agency’s scientific guidelines on excipients.

North America is followed by Europe due to the presence of large companies such as FMC Corporation and Avantor Performance Materials Inc. who are direct manufacturers. This region is expected to showcase a significant growth owing to the ongoing case studies based on drug-excipient interactions to increase delivery efficacy and efficiency.

Due to the high volume of unmet medical requirement and expanding generic market, Asia Pacific along with Middle East and Africa are anticipated to grow at a faster pace. Moreover, these regions are a good source of raw materials and enable low-cost manufacturing process for excipients.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com